THE ASSOCIATION OF DIVERSITY IN CLINICAL TRIALS

The Association of Diversity in Clinical Trials Launches Membership Portal

Retrieved on:

Friday, December 22, 2023

DALLAS, Dec. 22, 2023 /PRNewswire/ -- The Association of Diversity in Clinical Trials (AOD) announces the successful launch of its Membership Portal, attracting over 130 members.

Key Points:

DALLAS, Dec. 22, 2023 /PRNewswire/ -- The Association of Diversity in Clinical Trials (AOD) announces the successful launch of its Membership Portal, attracting over 130 members.
This emphasizes the commitment to advancing diversity in clinical trials.
"This reflects the urgent need and shared commitment to addressing diversity gaps in clinical trials.
This community is positioned to drive positive change and contribute significantly to advancing diversity and inclusivity in clinical trials.

Accelerated Cure Project for Multiple Sclerosis and Arab Board for Clinical Research Partner with the Association of Diversity in Clinical Trials

Retrieved on:

Thursday, September 28, 2023

AOD, MS, Clinical trial, Business development, Partnership, Research, Patient, Multiple sclerosis, Pharmaceutical industry, Nursing

DALLAS, Sept. 28, 2023 /PRNewswire/ -- The Association of Diversity in Clinical Trials (AOD) proudly announces its newest partners, Accelerated Cure Project for Multiple Sclerosis and Arab Board for Clinical Research.

Key Points:

DALLAS, Sept. 28, 2023 /PRNewswire/ -- The Association of Diversity in Clinical Trials (AOD) proudly announces its newest partners, Accelerated Cure Project for Multiple Sclerosis and Arab Board for Clinical Research.
The Arab Board for Clinical Research, renowned for its advocacy work in the clinical research space, joins forces with AOD to enhance diversity in clinical trials on a global scale.
"Our partnership with the Accelerated Cure Project for Multiple Sclerosis and the Arab Board for Clinical Research is a vital step in addressing clinical trial disparities," stated Jeremy Mitchell, AOD's Director of Business Development.
AOD, Accelerated Cure Project for Multiple Sclerosis, and the Arab Board for Clinical Research unite for a more inclusive healthcare future.

Association of Diversity in Clinical Trials Welcomes BlueCloud by HealthCarePoint.com as a Supporting Partner

Retrieved on:

Tuesday, September 12, 2023

AOD, Heart, GDPR, Religion, Privacy, PBC, Nursing

DALLAS, Sept. 12, 2023 /PRNewswire/ -- The Association of Diversity in Clinical Trials proudly announces the inclusion of BlueCloud by HealthCarePoint.com as our latest Supporting Partner.

Key Points:

DALLAS, Sept. 12, 2023 /PRNewswire/ -- The Association of Diversity in Clinical Trials proudly announces the inclusion of BlueCloud by HealthCarePoint.com as our latest Supporting Partner.
As a pioneer in modernized, decentralized regulatory and privacy networks in healthcare and clinical research, BlueCloud by HealthCarePoint.com joins hands with AOD in a united mission to champion diversity, inclusivity, and innovation within the clinical trials sector.
At the heart of BlueCloud's mission is improving clinical research efficiency while prioritizing patient well-being.
"Their innovative approach seamlessly aligns with our dedication to fostering inclusivity and equality in clinical trials.

CRIO Joins Forces with the Association of Diversity in Clinical Trials as a Supporting Partner to Drive Inclusive Research Advancements

Retrieved on:

Monday, August 14, 2023

AOD, Clinical trial, Partnership, CRIO, Research, Patient, ESourcing Capability Model, Medical device, Diversity

DALLAS, Aug. 14, 2023 /PRNewswire/ -- The Association of Diversity in Clinical Trials (AOD) and CRIO, a leading eSource technology provider, are excited to announce a new partnership.

Key Points:

DALLAS, Aug. 14, 2023 /PRNewswire/ -- The Association of Diversity in Clinical Trials (AOD) and CRIO, a leading eSource technology provider, are excited to announce a new partnership.
By joining the AOD as a Supporting partner, CRIO and CEO Raymond Nomizu, continue their commitment to being an ally in the improvement of Diversity in clinical trials.
"CRIO enables the start-up of new sites and investigators, enabling research in previously underserved communities, "says Raymond Nomizu, CEO at CRIO.
"CRIO supports the mission of Association of Diversity and looks forward to collaborating with other industry stakeholders to advance the mission."

BLACK WOMEN IN CLINICAL RESEARCH JOINS THE ASSOCIATION OF DIVERSITY IN CLINICAL TRIALS AS A SUPPORTING PARTNER BRINGING 15,000 MEMBERS TO PARTICIPATE IN AOD MEMBERSHIP

Retrieved on:

Wednesday, June 21, 2023

AOD, Certification, International Board Game Studies Association, Partnership, Environment, Nursing

DALLAS, June 21, 2023 /PRNewswire/ -- The Association of Diversity in Clinical Trials (AOD) announces a new partnership agreement with Black Women in Clinical Research (BWICR) allowing their 15,000 members an opportunity to participate in the extensive AOD benefits.

Key Points:

DALLAS, June 21, 2023 /PRNewswire/ -- The Association of Diversity in Clinical Trials (AOD) announces a new partnership agreement with Black Women in Clinical Research (BWICR) allowing their 15,000 members an opportunity to participate in the extensive AOD benefits.
The mission of the AOD is to establish standards and best practices for the clinical trials industry to improve the representation of diverse participants in clinical trials through the development, integration, and monitoring of quality and consistent diversity methodology across the research industry.
Addressing diversification of staff is one component of the AOD objective and BWICR will bring significant presence to this issue."
Dr. Diana Foster, President of the AOD, credits Danielle's story of having been blocked from entry into clinical research as the impetus behind her organization's mission.

DROX HEALTH SCIENCES JOINS THE ASSOCIATION OF DIVERSITY IN CLINICAL TRIALS AS A SUPPORTING PARTNER

Retrieved on:

Tuesday, May 23, 2023

AOD, Partnership, Hope, Research, Pharmaceutical industry

DALLAS, May 23, 2023 /PRNewswire/ -- The Association of Diversity in Clinical Trials (AOD), a diversity-focused organization whose mission is to set standards and best practices for the clinical trials industry to improve the representation of diverse participants in clinical trials announces a new supporting partner, DROX Health Science.

Key Points:

DALLAS, May 23, 2023 /PRNewswire/ -- The Association of Diversity in Clinical Trials (AOD), a diversity-focused organization whose mission is to set standards and best practices for the clinical trials industry to improve the representation of diverse participants in clinical trials announces a new supporting partner, DROX Health Science.
DROX is a contract research organization (CRO) headquartered in Miami with locations in Mexico and Germany that offers comprehensive clinical research management services.
Principal CEO of DROX Health Science, Marco Cid, shared, "This partnership is a significant step in bringing awareness to an issue that affects everyone globally.
By partnering with the AOD, we're able to address the longstanding issue of inadequate representation in clinical trials and hope to influence the outcome of trials around the world."

Announcing the Launch of The Association of Diversity in Clinical Trials

Retrieved on:

Friday, February 3, 2023

US, Health equity, Government, SCOPE, AOD, Macrocephaly, Surgeon General of the United States, Advisory board, Pharmaceutical industry, Nursing

DALLAS, Feb. 3, 2023 /PRNewswire/ -- The Association of Diversity in Clinical Trials (AOD) is being launched and introduced at upcoming industry conferences SCOPE and the Health Equity in Clinical Trials Congress this month.

Key Points:

DALLAS, Feb. 3, 2023 /PRNewswire/ -- The Association of Diversity in Clinical Trials (AOD) is being launched and introduced at upcoming industry conferences SCOPE and the Health Equity in Clinical Trials Congress this month.
The AOD will become the first entity to represent industry in an effort to meet new government and regulatory demands in the field of diversity.
This will be achieved through the development, integration, and monitoring of quality and consistent diversity methodology across the research industry.
A prestigious Advisory Board of leaders will be announced soon who will support this unprecedented step towards the assurance of representative diversity and inclusion in clinical trials.